BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18022932)

  • 1. Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors.
    Gruh I; Wunderlich S; Winkler M; Schwanke K; Heinke J; Blömer U; Ruhparwar A; Rohde B; Li RK; Haverich A; Martin U
    J Gene Med; 2008 Jan; 10(1):21-32. PubMed ID: 18022932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
    Ramezani A; Hawley TS; Hawley RG
    Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression.
    Ngai SC; Rosli R; Nordin N; Veerakumarasivam A; Abdullah S
    Gene; 2012 May; 498(2):231-6. PubMed ID: 22366305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
    Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
    Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.
    Mitta B; Rimann M; Ehrengruber MU; Ehrbar M; Djonov V; Kelm J; Fussenegger M
    Nucleic Acids Res; 2002 Nov; 30(21):e113. PubMed ID: 12409472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression.
    Lizée G; Aerts JL; Gonzales MI; Chinnasamy N; Morgan RA; Topalian SL
    Hum Gene Ther; 2003 Apr; 14(6):497-507. PubMed ID: 12718761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells.
    Li M; Husic N; Lin Y; Christensen H; Malik I; McIver S; LaPash Daniels CM; Harris DA; Kotzbauer PT; Goldberg MP; Snider BJ
    J Neurosci Methods; 2010 May; 189(1):56-64. PubMed ID: 20347873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II pneumocyte-restricted green fluorescent protein expression after lentiviral transduction of lung epithelial cells.
    Wunderlich S; Gruh I; Winkler ME; Beier J; Radtke K; Schmiedl A; Groos S; Haverich A; Martin U
    Hum Gene Ther; 2008 Jan; 19(1):39-52. PubMed ID: 18052721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
    Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
    Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric smooth muscle-specific enhancer/promoters: valuable tools for adenovirus-mediated cardiovascular gene therapy.
    Ribault S; Neuville P; Méchine-Neuville A; Augé F; Parlakian A; Gabbiani G; Paulin D; Calenda V
    Circ Res; 2001 Mar; 88(5):468-75. PubMed ID: 11249869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner.
    Ginn SL; Fleming J; Rowe PB; Alexander IE
    Hum Gene Ther; 2003 Aug; 14(12):1127-37. PubMed ID: 12908965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.
    Lotti F; Menguzzato E; Rossi C; Naldini L; Ailles L; Mavilio F; Ferrari G
    J Virol; 2002 Apr; 76(8):3996-4007. PubMed ID: 11907239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional promoter testing using a modified lentiviral transfer vector.
    Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
    Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner.
    Xia X; Zhang Y; Zieth CR; Zhang SC
    Stem Cells Dev; 2007 Feb; 16(1):167-76. PubMed ID: 17348812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
    Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
    Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.
    Zhang F; Thornhill SI; Howe SJ; Ulaganathan M; Schambach A; Sinclair J; Kinnon C; Gaspar HB; Antoniou M; Thrasher AJ
    Blood; 2007 Sep; 110(5):1448-57. PubMed ID: 17456723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
    Liu BH; Wang X; Ma YX; Wang S
    Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes.
    Lutzko C; Senadheera D; Skelton D; Petersen D; Kohn DB
    J Virol; 2003 Jul; 77(13):7341-51. PubMed ID: 12805432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.